Customer Service:
Mon - Fri: 8:30 am - 6 pm EST
Back
Standards PDF Cover Page preview

 Historical

CLSI EP07-A2

Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition

This document provides background information, guidance, and experimental procedures for investigating, identifying, and characterizing the effects of interfering substances on clinical chemistry test results. The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement

Available for Subscriptions

Content Provider
Clinical And Laboratory Standards Institute [clsi]

Others Also Bought

CLSI EP25-A Vol. 29 No. 20
Diagnostic Reagents; Approved Guideline Stability of In Vitro Diagnostic Reagents; Approved Guideline
Subscription Option
CLSI EP05-A3
Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline - Third Edition
Subscription Option
CLSI EP17-A2
Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline -Second Edition ...
Add to cart
Document History
Revised By:
Included in Packages
This standard is not included in any packages.
Amendments & Corrections
We have no amendments or corrections for this standard.
ANSI Logo

As the voice of the U.S. standards and conformity assessment system, the American National Standards Institute (ANSI) empowers its members and constituents to strengthen the U.S. marketplace position in the global economy while helping to assure the safety and health of consumers and the protection of the environment.

Useful Links
CUSTOMER SERVICE
NEW YORK OFFICE
ANSI HEADQUARTERS
2024 © American National Standards Institute (ANSI) All Rights Reserved.